Demographic epidemiologic projections of long-term care needs in selected European countries Germany, Spain, the Netherlands and Poland by Bonneux, L.G.A. et al.
 
European Network of Economic 
Policy Research Institutes 
ANCIEN 
Assessing Needs of Care in European 
Nations 
 
 
 
 
 
DEMOGRAPHIC EPIDEMIOLOGIC PROJECTIONS 
OF LONG-TERM CARE NEEDS 
IN SELECTED EUROPEAN COUNTRIES 
 GERMANY, SPAIN, THE NETHERLANDS AND POLAND 
 
LUC BONNEUX, NICOLE VAN DER GAAG, 
GOVERT BIJWAARD, ESTHER MOT AND PETER WILLEMÉ 
 
 
ENEPRI POLICY BRIEF NO. 8 
 
 
FEBRUARY 2012 
 
 
 
 
 
 
 
 
Available for free downloading from the CEPS website (www.ceps.eu) and 
ANCIEN website (http://www.ancien-longtermcare.eu/ 
© Copyright 2012 Luc Bonneux, Nicole Van der Gaag, Govert Bijwaard, Esther Mot and Peter Willemé 
ENEPRI Policy Briefs extract the policy implications of research carried out by 
member institutes of the European Network of Economic Policy Research Institutes. 
Initiated by CEPS in 1999, ENEPRI conducts research on welfare and employment 
issues with the aim of diffusing research, coordinating research plans and increasing 
the awareness of the European dimension in national problems (see www.enepri.org). 
The research presented in this Policy Brief was conducted under the ANCIEN project 
(Assessing Needs of Care in European Nations), which focuses on the future of long-
term care for the elderly in Europe. Funding for the project is received from the 
European Commission under the 7
th Framework Programme (FP7 Health-2007-3.2.2, 
Grant no. 223483). See the back page for more information “About ANCIEN”. The 
results and conclusions of this paper are those of the authors and are not attributable to 
Eurostat, the European Commission or any of the national authorities whose data have 
been used. The views expressed are attributable only to the authors in a personal 
capacity and not to any institution with which they are associated. | 1 
DEMOGRAPHIC EPIDEMIOLOGIC PROJECTIONS 
OF LONG-TERM CARE NEEDS 
IN SELECTED EUROPEAN COUNTRIES 
GERMANY, SPAIN, THE NETHERLANDS AND POLAND 
LUC BONNEUX, NICOLE VAN DER GAAG, GOVERT BIJWAARD, 
ESTHER MOT AND PETER WILLEMÉ
* 
ENEPRI POLICY BRIEF NO. 8/FEBRUARY 2012 
Summary 
The objectives of Work Package (WP) 2 of the EU FP7 project ANCIEN are to assess the actual and 
future numbers of elderly care-dependent persons in selected countries. Such projections are needed to 
support planning to meet future needs for long-term care (LTC) across the EU. We have selected four 
countries for projections of LTC needs: Spain, Poland, Germany and the Netherlands. These countries 
are representative of European epidemiology and of different systems for the provision of long-term 
care.  
We have used the mortality forecasts of the EUROPOP 2008 scenarios as a basis for projections of the 
number of disabled elderly persons, according to several assumptions about how disability and 
mortality are related. We have added scenarios on the effects of smoking and obesity (BMI). Data 
have also been derived from Eurostat (forecasts of mortality and populations), ANCIEN WP 1 (the 
elderly living in institutions), the SHARE project (the elderly living in the community) and the 
Rotterdam Study (on ageing).  
The main determinant of the future numbers of the disabled elderly has turned out to be the 
demographic ageing of the large baby boom cohorts. This is projected to cause increases of 44% 
(Germany), 65% (Spain), 82% (the Netherlands) and 57% (Poland). The impact of life extension 
depends on the correlation of disability in old age and mortality, and is moderate under reasonably 
conservative assumptions (with rises of 11% for Germany, 7% for Spain, 9% for the Netherlands and 
22% for Poland). For Poland, convergence with Germany on the onset of disability in terms of timing 
would limit this increase. Obesity and (quitting) smoking have little effect – increasing levels of 
disability by around 2 percentage points per absolute increase in the prevalence of obesity of 5%, 
while quitting smoking has even less effect.  
We conclude that the future numbers of long-term care recipients can be robustly predicted and will be 
mainly determined by demographic ageing.  
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1.  Introduction: Defining and forecasting long-term care needs  
The large post-War baby boom began in 1946 and its cohorts reached the retirement age of 65 starting 
in 2011. A ‘baby crash’ (a sharp decline in fertility) followed the baby boom. This imbalance between 
the large baby boom generations and the small baby crash generations born after the 1970s determines 
future population ageing: large numbers of elderly persons aged 65+ followed by few adults. Policy 
questions related to the provision of health and long-term care services in an ageing population need 
reliable forecasts of the numbers of disabled elderly persons. In this Policy Brief, we use demographic 
models to project the future need for long-term care in four countries of the EU: Germany (DE), Spain 
(ES), the Netherlands (NL) and Poland (PL), based on the EUROPOP 2008 mortality forecasts 
(Giannakouris, 2010).
. The methods developed are generic and easily applicable to all countries that 
can produce mortality data and prevalence data on limitations in activities of daily living (ADLs) and 
selected risk factors. 
Disability and morbidity are descriptions of health states with many dimensions. We are most 
interested in severe disability, leading to a loss of independence and the need for help in self care 
(Katz et al., 1963). This is operationalised as having at least one limitation in basic activities of daily 
living (subsequently referred to as an ADL disability), defined as self-reported difficulty with any of 
the following actions: a) bathing, b) dressing, c) eating, d) indoor transfers and e) toileting and 
continence. 
The prevalence of disability is determined by incidence and survival in that state. To assess dynamic 
changes in populations, we need information on dynamic change – how people flow into disability and 
out of life (Barendregt, Bonneux and Van der Maas, 1994). Projections of disability are based on the 
future numbers of persons entering old age (demographic change), the length of time they will live as 
elderly individuals (mortality and life expectancy), the probability that they will become disabled and 
the length of time they will survive being disabled (epidemiology of disability).  
We seek answers to three questions. First, what will be the consequences of the demographic increase 
of elderly cohorts? Second, what will be the consequences of the life extension of these cohorts 
(sometimes called ‘double ageing’)? And third, what will be the consequences of a changing 
What is known: 
•  The large post-War baby boom cohorts start to turn 65 in 2011, bringing large increases in the 
shares of the population aged 65 and older in Europe.  
•  These cohorts will live to older ages with apparently higher risks of age-related disability. 
•  Changes in smoking and obesity may increase the prevalence of disability further. 
What this project has added: 
•  Evidence shows that life extension is correlated with life extension free of (severe) disability; 
this will limit the increase in the prevalence of disability in populations living to older ages.  
•  Lower smoking rates increase survivorship, but have only a small effect on the prevalence of 
disability.  
•  A higher prevalence of obesity increases the prevalence of disability attributable to obesity, but 
this increase is relatively limited compared with the demographic growth in the numbers of the 
elderly. 
Relevance for European policies on long-term care: 
•  The prevalence of the (severely) disabled elderly can be robustly estimated, and it largely 
depends on the demography of the population aged 65 and older. 
•  For a better understanding of the European epidemiology of (severe) disability, more data on 
the incidence, prevalence and recovery at older ages are urgently needed. DEMOGRAPHIC EPIDEMIOLOGIC PROJECTIONS OF LTC NEEDS IN GERMANY, SPAIN, THE NETHERLANDS & POLAND | 3 
epidemiology with the known effects on disability of smoking and obesity (Reuser, Bonneux and 
Willekens, 2009)? 
The EUROPOP 2008 forecasts are the basis of our demographic and mortality forecasts. The first 
question is answered by baseline demographic projections assuming constant mortality and incidence 
after age 55, projecting the forecasted increase of populations reaching age 55 in the period 2008–60. 
Information on the numbers of the disabled elderly currently living in the community is taken from the 
large European study, SHARE (the Survey of Health, Ageing and Retirement in Europe),
1 
complemented with estimates of the numbers of the elderly living in institutions, derived from WP 1 
of the ANCIEN project.  
The second question is answered by the forecasted mortality at age 65 and older, and by the relation 
between disability and mortality. This relation is determined by ageing: age since birth as a proxy of 
wear and tear (or chronology, ‘Chron’ in our scenarios) and age before death as a proxy of biological 
age, characterising the resilience of the organism against the ageing process (‘Biol’, from biology in 
our scenarios). The effect of increasing life expectancy is assessed by three scenarios studying 
different morbidity scenarios. A chronological scenario (Chron) assumes increasing life expectancy 
but a constant incidence of age-specific disability. This is an “expansion of morbidity scenario”, 
predicting longer life by increased survival of the diseased (Manton, 1982; Olshansky et al., 1991). 
The biological scenario (Biol) assumes equal trends in mortality and disability (Cai and Lubitz, 2007; 
Christensen et al., 2009; Manton, 1982; Mitnitski et al., 2002; Payne et al., 2007). A similar but more 
conservative scenario assumes that the incidence of disability is delayed similar to mortality (‘Delay’). 
The former socialist countries of Europe, here exemplified by Poland, are lagging behind in life 
expectancy. The EUROPOP scenarios (and most scholars) assume that these countries will catch up: 
mortality scenarios assume convergence. Therefore, we have also added a scenario of future 
convergence in terms of disability in Poland (‘Convergence’).  
The third question is answered by epidemiologic scenarios. We modelled the effects of lifestyles 
(smoking and obesity) as categorical variables. Gender- and age-specific mortality by disability were 
identified by using data from the Rotterdam Study Project (Hofman et al., 2009) and the prevalence 
conditional on risk factors was defined by the SHARE study.  
2.  Evidence and analysis 
In Germany, life expectancy for women at age 65 was 20.1 years and for men it was 16.8 years in 
2008. This life expectancy is split into two parts: disabled and not disabled. German men were 
expected to live 3.3 years with an ADL disability and German women 4.8 years (reflecting the higher 
prevalence of disability among women). Women experience disability more often than men; also, the 
prevalence of disability is very low among Dutch men and a bit higher among Spanish women. Poland 
is characterised by a high mortality rate, particularly among men, and a high prevalence of disability. 
Such a rapid age-related decline in physical function has also been documented in Russia (Bobak et 
al., 2004). 
The EUROPOP 2008 scenario assumes that in 2040, more than three years of life expectancy are 
added by lowered mortality (somewhat more than a year per decade). In a biological scenario, the 
increase in the duration of disability would be close to nil (data not shown): this scenario assumes that 
late-age disability is timed by the date of death, not by the date of birth, so life extension postpones 
both death and disability and solely adds healthy years. In a chronological scenario, half of the gained 
life expectancy is spent in disability (data not shown). This reflects the high prevalence of disability at 
older ages, but assumes that disability at old age and mortality are independent processes. In the less 
extreme Delay scenario (shown in Table 1), the increase in the duration of disability is more moderate. 
The scenario of Poland’s convergence with Germany on disability incidence shows that even a strong 
assumption of convergence (with an equal disability incidence in 2040) will still have a limited effect 
on disability prevalence (not shown): reducing flows (incidence) has a slow effect on the remaining 
shares (prevalence). 
                                                      
1 See the SHARE website at http://www.share-project.org/. 4 | BONNEUX, VAN DER GAAG, BIJWAARD, MOT & WILLEMÉ 
Table 1. Life expectancies at age 65, by period (2008 and 2040), gender and disability status 
  F    M   
   e 65 nDe65 De65 e 65 nDe65 De65 
Germany        
2008  20.10 15.35  4.75 16.87 13.56  3.32 
2040  Delay  23.34 17.78  5.56 20.37 16.25  4.12 
Spain        
2008  20.96 14.87  6.09 17.14 13.79  3.35 
2040  Delay  23.89 17.02  6.87 20.48 16.37  4.11 
The Netherlands        
2008  19.94 15.64  4.30 16.59 14.39  2.20 
2040  Delay  23.25 18.26  4.99 19.99 17.26  2.73 
Poland        
2008  18.56  10.85 7.71  14.50 9.91 4.59 
2040  Delay  22.37 12.89  9.48 18.77 12.45  6.31 
Convergence  22.62 14.47  8.14 19.05 13.44  5.61 
Notes: F is female, M is male, e65 is life expectancy, nDe65 is life expectancy free of disability and De65 is life 
expectancy with disability, all at age 65. For scenarios, see text. 
To the individual life expectancies of Table 1, we have added the population effects of demography, in 
order to show the developments in the number of the disabled elderly (Figure 1).  
Figure 1. Change in basic ADLs among the disabled elderly in 2040 compared with 2008 
 
Notes: ‘Demo’ is the expected change assuming constant mortality and incidence. Life extension adds the 
numbers of the intermediate ‘Delay’ scenario. ‘Chron’ adds the numbers if the incidence of disability remained 
constant.  
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If incidence and mortality remain constant, all increases will be caused by demographic increases 
alone. In Germany, the increase in the elderly caused by the baby boom will be low (+44%), while it 
will be high in the Netherlands (+82%) and intermediate in Poland and Spain (respectively +57% and 
+65%). A constant disability incidence (or prevalence) but lowered mortality rate would be a ‘worst 
case disability scenario’ (Chron). In most countries, the prevalence of disability would double. In the 
Netherlands, the number of the disabled elderly would even increase by an additional 140%. The 
somewhat more optimistic Delay scenario shows the effect of a modest decline in the disability 
incidence. In Germany, the Netherlands and Spain, the increase in disability by life extension 
combined with a delay in the onset of disability would be between 7 and 11%, caused by ageing. In 
Poland, this figure would be 22%, a consequence of the high prevalence of disability and more 
pronounced increases in life expectancy. If mortality converges, however, it is not reasonable to 
assume no convergence of disability. Convergence with Germany would limit the effects of life 
extension on disability by 5 percentage points, mostly as a consequence of a historically high 
prevalence of disability. But it would never fall under a demographic scenario. 
Table 2 shows the consequences of differences in the risk factors of obesity and smoking for the 
cohorts in the German life table. Relative mortality weights for obesity and smoking are based on the 
studies of Walter et al. (2009) and Majer et al. (2011b). With risk factor-specific prevalence of 
disability, we are able to calculate the risk factor-specific incidence of disability (van der Gaag et al., 
2012). For reasons of brevity, only Germany is shown. 
Table 2. Healthy life expectancies at age 65 by risk factor status in 2008  
2008 Women  Men 
  e65 nD  e65 D  e65 e 65 nD  e65 D  e65 
Germany        
EUROPOP 20.07  –  – 16.82  –  – 
ANCIEN  20.10 15.35  4.75 16.87 13.56  3.32 
nS  20.33 15.49  4.84 17.33 13.87  3.46 
S  16.47 13.13  3.34 13.66 11.49  2.16 
nO  20.22 15.88  4.34 16.92 13.59  3.33 
O  19.73 13.39  6.33 16.56 13.09  3.47 
Notes: e65 is life expectancy, nD e 65 is life expectancy free of disability and D e 65 is life expectancy with 
disability. NS and NO and are non-smokers and non-obese persons, respectively, while S is smokers and O is 
obese persons. All data are in years. 
 
Smoking decreases the duration of disability by a high mortality rate (Barendregt, Bonneux and van 
der Maas, 1997; Al Mamun et al., 2004; Reuser, Bonneux and Willekens, 2009). Obesity increases the 
risks of disability, particularly among women.
2 Smokers’ life expectancy is nearly 4 years shorter. The 
lives of obese individuals are not much shorter, but those of obese women are nearly 2.5 years shorter 
in which they are free of disability, and two years longer with a disability. The scenarios assume that 
future mortality and incidence are risk factor-dependent, but that the changes over time in mortality 
and incidence are risk factor-independent (the forecasted changes, in % per year, are equal among the 
obese and non-obese).  
Figure 2 shows the consequences of different obesity scenarios. The ‘Lean’ scenario assumes that the 
prevalence of obesity will halve (and reach the levels of the 1960s again). The ‘Fat’ scenario assumes 
that the prevalence of obesity will double (and reach the levels of the US). These scenarios are 
extreme, as we assume the change to have occurred in 2008.  
 
                                                      
2 See Al Snih et al. (2007), Alley and Chang (2007), Peeters et al. (2004), Reuser, Bonneux and Willekens 
(2009), Sturm, Ringel and Andreyeva (2004), Walter et al. (2009) and Majer et al. (2011b). 6 | BONNEUX, VAN DER GAAG, BIJWAARD, MOT & WILLEMÉ 
Figure 2. Change in ADLs among the disabled elderly in 2040 compared with 2008, obesity scenarios 
 
Notes: The obesity scenarios show the consequences of the Delay scenario adjusted for heterogeneity in BMI. In 
‘Lean’, the prevalence of obesity in the future cohorts halves. ‘BMI’ adds the numbers of disabled persons when 
the prevalence of obesity remains constant at the values of 2008. In ‘Fat’ the prevalence of obesity doubles.  
But even these extreme scenarios, with large consequences for the individual life course, have a rather 
limited impact on the prevalence of disability. Every individual born before 1975 will contribute to the 
prevalence of disability among those aged 65+ in 2040, while only the obese fraction in that 
population can contribute to the excess prevalence of disability, caused by obesity.  
Smoking trends are implicitly taken into account by the EUROPOP 2008 forecast methodology. These 
have been a major cause of the mortality decline among men in European democracies since the 
1970s, but not among European women, born before the Second World War: by societal consensus, 
these generations of girls were not allowed to smoke. This changed after the War. The female baby 
boom generation took up smoking in large(r) numbers, and will pay the price with increased mortality. 
In general, this means that the future decline of female mortality is overestimated by the EUROPOP 
mortality scenario, while the future decline of male mortality is underestimated.  
As shown in Figure 3, ‘Smok’ adds the numbers of disabled persons when the prevalence of smoking 
remains constant at the values of the young cohorts in 2008. This ignores the successful quitting of 
future diseased smokers: due to a (very) high mortality rate among disabled smokers who do not quit, 
ignoring this possibility would lower disability. ‘Trend’ is a realistic scenario assuming a slowly 
declining prevalence (2% per year) and successful quitting at a rate of 2% per year. ‘Quit’ is an 
accelerated quitting scenario, where no younger cohorts are smoking and smokers quit at an 
accelerated rate. The difference between the Smok and Trend scenarios shows that quitting among 
smokers is the most important cause of the increase in disability: smokers with disease try to stop. If 
they do not, their prognosis is poor and disability will be lowered by a very high mortality rate. But 
this is common to all curable diseases – quitting smoking is the single most important preventive and 
therapeutic action among smokers with disease.  
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Figure 3. Change in ADLs among the disabled elderly in 2040 compared with 2008, smoking 
scenarios 
 
Notes: The smoking scenarios show the consequences of the Delay scenario adjusted for heterogeneity in 
smoking behaviour. In ‘Smok’, the prevalence of smoking remains constant at the values of the young cohorts in 
2008. ‘Trend’ is a realistic scenario assuming a slowly declining prevalence (2% per year) and adding successful 
quitting at a rate of 2% per year. ‘Quit’ is an accelerated quitting scenario, where no new inflowing cohorts are 
smoking and smokers quit at accelerated rates.  
3.  Policy implications and recommendations 
The scenarios show the overriding influence of demographic change on future disability. The 
demographic projections for 2040 are robust: in the life table, 95% of babies will survive until age 55. 
Life extension is the second most important force driving the increase in disability. The simple linear 
forecasts of the EUROPOP scenarios project a period of unprecedented decline in mortality among 
those aged 55+ from the second half of the 20
th century to the future. Yet the predicted life expectancy 
among women aged 65 in 2040 is still lower in the EU than the actual female life expectancy in Japan 
at age 65 in 2009 (24.0 years); thus, this is not an unreasonable scenario.  
Assuming a constant disability incidence with sharply decreasing mortality (the chronology scenario) 
would be pessimistic and not consistent with theories of ageing. For the time being, and for severe 
disability, there is strong support for more biological scenarios.
3 At the same time, assuming sharply 
decreasing disability while little progress is observed in cognitive causes of disability may be too 
optimistic. Still, the numbers of life years lived with disability remained surprisingly constant in the 
Netherlands as in other countries (Maier, 2011). The intermediary Delay scenario is a somewhat more 
conservative estimate of the biological scenario, which is a safe basis for projections used in policy 
preparation.  
The effects of changing risk factors on the prevalence of disability are surprisingly small. First, there is 
demographic inertia: it takes many years to replace populations. People start smoking as teenagers and 
they will die as smokers or quitters six decennia later. Second, every person born between 1943 and 
1975 will add to the population of the elderly at risk of disability, but only a fraction of that population 
is at an increased risk by disabling lifestyles. If one-sixth is disabled when not obese but one-third is if 
                                                      
3 See Cai and Lubitz (2007), Christensen et al. (2009), Freedman et al. (2004), Freedman, Martin and Schoeni 
(2002), Gill et al. (2010), Majer et al. (2011a), Manton, Gu and Ukraintseva (2005), Manton (2008), Sagardui-
Villamor et al. (2005). 
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obese, and 20% are obese, the attributable risk is 3%. If the prevalence of obesity doubles, from 20% 
to 40%, the attributable risk doubles to 6% and the prevalence of disability increases from 20% to 
23%. If for instance in the Netherlands the population aged 65+ were to double from 100 to 200, there 
would be 47 disabled individuals among these 200 persons: 20 would be added because of the 
doubling of the population and 7 would be added because of doubled obesity. The numbers are 
relatively limited compared with the demographic increase. Note that the assumptions of both change 
(a doubling of the prevalence of obesity) and risk (a doubled risk) are extreme, and true increases in 
attributable risk would be smaller. 
The effects of quitting smoking are associated with life extension. Smoking shortens life and shortens 
life with disability. Many smokers improve the prognosis of their disease considerably by quitting and 
extended survival by lifestyle modification can hardly be called a disadvantage. Yet even extreme 
scenarios would not add many disabled elderly persons. 
A most important conclusion is that the future numbers of the disabled elderly can be forecasted 
robustly and will be determined for a large part by demographic change. Lowered mortality rates 
increase life expectancy, but being a result of progress, it is predominantly a life expectancy free of 
disability. Obesity increases disability, but only the added obese are at a higher risk. Successful anti-
obesity policies will lower the number of disabled elderly persons only modestly. Smokers suffer more 
from lethal diseases – but the population effects are small and mostly caused by smokers who do not 
quit. Successful policies that help smokers to quit will increase life expectancy, with the consequence 
of only a very moderate increase in the number of the disabled elderly.  
Ageing will cause sharp increases in the numbers of the disabled elderly, but these increases are easily 
foreseeable over several decennia and planning for future resources can be initiated in a timely 
manner. 
4.  Research parameters 
We assumed equal mortality trends for disabled and non-disabled persons, and for persons with or 
without different risk statuses. This might not be true. Indeed, for dementia (a most important cause of 
disability), we can observe lower mortality at early stages but increased mortality at later clinical 
stages among more highly educated people – a consequence of more successful adaptation to cognitive 
decline by highly educated persons (Reuser, Willekens and Bonneux, 2011). More highly educated 
people can stave off clinical dementia until they reach advanced stages of severe disease and poor 
prognosis. Future research should focus more on postponing disability by promoting adaptation to the 
unavoidable impairments of old age. 
The data on the prevalence of disability are very weak. The prevalence of ADL disability is highest 
among the oldest old, but data on prevalence are scarce and trend data nearly absent. We have more 
confidence in the reliability of the modelled trends than in the national point estimates of ADL 
disability for 2008. With longer follow-up, SHARE can inform us about trends in prevalence, and 
maybe even incidence. Yet the quality of the follow-up will be of utmost importance. Disability and 
mortality are easily lost in follow-up, which will bias incidence, prevalence and the survival of 
disabled persons towards lower values. We strongly advise the investment of more resources in the 
SHARE project, and particularly in the follow-up of SHARE participants in order to collect reliable 
data. 
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aunched in January 2009, ANCIEN is a research project financed under the 7th EU Research 
Framework Programme. It runs for a 44-month period and involves 20 partners from EU member 
states. The project principally concerns the future of long-term care (LTC) for the elderly in Europe 
and addresses two questions in particular: 
1) How will need, demand, supply and use of LTC develop? 
2) How do different systems of LTC perform? 
The project proceeds in consecutive steps of collecting and analysing information and projecting future 
scenarios on long-term care needs, use, quality assurance and system performance. State-of-the-art 
demographic, epidemiological and econometric modelling is used to interpret and project needs, supply and 
use of long-term care over future time periods for different LTC systems. 
Work Packages. The project started with collecting information and data to portray long-term care in 
Europe (WP 1). After establishing a framework for individual country reports, including data templates, 
information was collected and typologies of LTC systems were created. The collected data will form the 
basis of estimates of actual and future long term care needs in selected countries (WP 2). WP 3 builds on the 
estimates of needs to characterise the response: the provision and determinants of formal and informal care 
across European long-term care systems. Special emphasis is put on identifying the impact of regulation on 
the choice of care and the supply of caregivers. WP 6 integrates the results of WPs 1, 2 and 3 using 
econometric micro and macro-modelling, translating the projected needs derived from WP2 into projected 
use by using the behavioral models developed in WP3, taking into account the availability and regulation of 
formal and informal care and the potential use of technological developments. 
On the back of projected needs, provisions and use in European LTC systems, WP 4 addresses developing 
technology as a factor in the process of change occurring in long-term care. This project will work out 
general principles for coping with the role of evolving technology, considering the cultural, economic, 
regulatory and organisational conditions. WP 5 addresses quality assurance. Together with WP 1, WP 5 
reviews the policies on LTC quality assurance and the quality indicators in the EU member states, and 
assesses strengths, weaknesses, opportunities and threats of the various quality assurance policies. Finally 
WP 7 analyses systems performance, identifying best practices and studying trade-offs between quality, 
accessibility and affordability. 
The final result of all work packages is a comprehensive overview of the long term care systems of EU 
nations, a description and projection of needs, provision and use for selected countries combined with a 
description of systems, and of quality assurance and an analysis of systems performance.  
Principal and Partner Institutes 
CEPS is responsible for administrative coordination and dissemination of the general results (WP 8 and 9). 
The Belgian Federal Planning Bureau (FPB) and the Netherlands Bureau for Economic Policy Analysis 
(CPB) are responsible for scientific coordination. Other partners include: German Institute for Economic 
Research (DIW); Netherlands Interdisciplinary Demographic Institute (NIDI); Fundación de Estudios de 
Economía Aplicada (FEDEA); Consiglio Nazionale delle Ricerche (CNR); Universitá Luiss Guido Carli-
Luiss Business School (LUISS-LBS); Institute for Advanced Studies (IHS); London School of Economics 
and Political Science- Personal Social Services Research Unit  (PSSRU); Istituto di Studi e Analisi 
Economica (ISAE); Center for Social and Economic Research (CASE); Institute for Economic Research 
(IER); Social Research Institute (TARKI); The Research Institute of the Finnish Economy (ETLA); 
Université de Paris-Dauphine-Laboratoire d`Economie et de Gestion des organisations de Santé 
(DAUPHINE- LEGOS); University of Stockholm, Department of Economics; Karolinska Institute- 
Department of Medecine, Clinical Epidemiology Unit ; Institute of Economic Research, Slovak Academy of 
Sciences (SAS-BIER); Center for Policy studies (PRAXIS). Most of the ANCIEN partners are members of 
the European Network of Economic Policy Research Institutes (ENEPRI). 
For more information, please visit the ANCIEN website (www.ancien-longtermcare.eu)  
or the CEPS website (www.ceps.eu). 
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